ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
256.00
-0.57 (-0.22%)
Oct 29, 2025, 11:45 AM EDT - Market open
ResMed Market Cap
ResMed has a market cap or net worth of $37.36 billion as of October 29, 2025. Its market cap has increased by 5.72% in one year.
Market Cap
37.36B
Enterprise Value
37.09B
1-Year Change
5.72%
Ranking
Category
Stock Price
$256.00
Market Cap Chart
Since December 1, 1998, ResMed's market cap has increased from $485.80M to $37.36B, an increase of 7,590.58%. That is a compound annual growth rate of 17.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 37.57B | 11.90% |
| Dec 31, 2024 | 33.57B | 32.68% |
| Dec 29, 2023 | 25.30B | -17.01% |
| Dec 30, 2022 | 30.49B | -19.68% |
| Dec 31, 2021 | 37.96B | 23.23% |
| Dec 31, 2020 | 30.80B | 38.24% |
| Dec 31, 2019 | 22.28B | 37.32% |
| Dec 31, 2018 | 16.23B | 35.02% |
| Dec 29, 2017 | 12.02B | 37.39% |
| Dec 30, 2016 | 8.75B | 16.66% |
| Dec 31, 2015 | 7.50B | -4.09% |
| Dec 31, 2014 | 7.82B | 16.86% |
| Dec 31, 2013 | 6.69B | 12.47% |
| Dec 31, 2012 | 5.95B | 40.80% |
| Dec 30, 2011 | 4.22B | -19.35% |
| Dec 31, 2010 | 5.24B | 33.67% |
| Dec 31, 2009 | 3.92B | 38.11% |
| Dec 31, 2008 | 2.84B | -30.14% |
| Dec 31, 2007 | 4.06B | 8.50% |
| Dec 29, 2006 | 3.74B | 38.30% |
| Dec 30, 2005 | 2.71B | 56.41% |
| Dec 31, 2004 | 1.73B | 22.93% |
| Dec 31, 2003 | 1.41B | 39.73% |
| Dec 31, 2002 | 1.01B | -41.47% |
| Dec 31, 2001 | 1.72B | 39.28% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.90B |
| Johnson & Johnson | 457.53B |
| AbbVie | 402.83B |
| UnitedHealth Group | 331.46B |
| AstraZeneca | 259.35B |
| Novartis AG | 250.89B |
| Novo Nordisk | 235.38B |
| Abbott Laboratories | 221.35B |